The Lancet in conversation with
Ein Podcast von The Lancet Group - Freitags
658 Folgen
-
Shawn St Peter on appendicectomy versus antibiotics for acute uncomplicated appendicitis in children
Vom: 27.1.2025 -
Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease
Vom: 9.1.2025 -
Nusrat Husain, Farah Lunat, and Fehmida Motala on postnatal depression in British south Asian women (the ROSHNI-2 trial)
Vom: 31.10.2024 -
Rasha Al-Lamee and Shayna Chotai on ESC 2024 highlights
Vom: 10.10.2024 -
Dr Oriol Mitjà and Dr Hypolite Muhindo Mavoko on mpox
Vom: 5.9.2024 -
Natasha Pocovi on the prevention of low back pain recurrence
Vom: 8.8.2024 -
Prasad Kulkarni on a vaccine against typhoid and paratyphoid
Vom: 2.5.2024 -
Patricia Campbell and Frans Rutten on heart failure with preserved ejection fraction
Vom: 28.3.2024 -
Lene Seidler on umbilical cord management at preterm birth
Vom: 21.12.2023 -
Emily Chew on the future of treatments for geographic atrophy
Vom: 26.10.2023 -
Simon Kyle on a new effective treatment for insomnia
Vom: 31.8.2023 -
Verna Vanderpuye and Isabelle Soerjomataram on International Women's Day and cancer
Vom: 8.3.2022 -
Nick James on the STAMPEDE trial
Vom: 23.12.2021 -
Jie Qiao (in English) on reproductive health in China
Vom: 2.6.2021 -
Jie Qiao (in Chinese) on reproductive health in China
Vom: 2.6.2021 -
Siobhan Quenby & Arri Coomarasamy on miscarriage
Vom: 26.4.2021 -
Muir Gray
Vom: 25.2.2021 -
Mary Bassett
Vom: 11.2.2021 -
Richard Horton on the Oxford vaccine phase 3 trial
Vom: 8.12.2020 -
Renee Salas
Vom: 2.12.2020
Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.
